Firebrick Pharma (ASX:FRE) Cash Flow from Operations : A$-1.93 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the six months ended in Dec. 2024, Firebrick Pharma's Cash Receipts from Operating Activities was A$0.97 Mil. Its Cash Payments was A$-1.58 Mil. Its Dividends Paid was A$0.00 Mil. Its Dividends Received was A$0.00 Mil. Its Interest Paid was A$0.00 Mil. Its Interest Received was A$0.01 Mil. Its Taxes Refund Paid was A$0.00 Mil. And its Cash Flow from Others was A$0.00 Mil. In all, Firebrick Pharma's Cash Flow from Operations for the six months ended in Dec. 2024 was A$-0.60 Mil.

Firebrick Pharma Cash Flow from Operations Historical Data

The historical data trend for Firebrick Pharma's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Cash Flow from Operations Chart

Firebrick Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

Cash Flow from Operations

-4.20

-5.78

-2.35

Firebrick Pharma Semi-Annual Data
	Jun21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Cash Flow from Operations	Get a 7-Day Free Trial			-2.19	-3.59	-1.01	-1.33	-0.60

Firebrick Pharma Cash Flow from Operations Calculation

Firebrick Pharma's Cash Flow from Operations for the fiscal year that ended in Jun. 2024 is calculated as:

	Cash Flow from Operations		(A: Jun. 2024 )
=	Cash Receipts from Operating Activities	+	Cash Payments	+	Dividends Paid	+	Dividends Received
=	-0.428	+	-1.934	+	0	+	0
+	Interest Paid	+	Interest Received	+	Taxes Refund Paid	+	Cash Flow from Others
+	0	+	0.017	+	0	+	0
=	-2.35

Firebrick Pharma's Cash Flow from Operations for the quarter that ended in Dec. 2024 is:

	Cash Flow from Operations		(Q: Dec. 2024 )
=	Cash Receipts from Operating Activities	+	Cash Payments	+	Dividends Paid	+	Dividends Received
=	0.973	+	-1.575	+	0	+	0
+	Interest Paid	+	Interest Received	+	Taxes Refund Paid	+	Cash Flow from Others
+	0	+	0.005	+	0	+	0
=	-0.60

Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-1.93 Mil.

Firebrick Pharma (ASX:FRE) Cash Flow from Operations Explanation

For non-financial companies reported in direct method, cash flow from operations contains eight items:

1. Cash Receipts from Operating Activities:
Cash Receipts from Operating Activities represents cash received from operating activitiies in direct method.

Firebrick Pharma's cash receipts from operating activities for the six months ended in Dec. 2024 was A$0.97 Mil.

2. Cash Payments:
It represents cash flow paid from operating activities in the direct cash flow method.

Firebrick Pharma's cash payments for the six months ended in Dec. 2024 was A$-1.58 Mil.

3. Dividends Paid:
It represents dividend paid to the investors in the direct cash flow method.

Firebrick Pharma's cash payments for the six months ended in Dec. 2024 was A$0.00 Mil.

4. Dividends Received:
It represents dividend received on the investment in the direct cash flow method.

Firebrick Pharma's cash payments for the six months ended in Dec. 2024 was A$0.00 Mil.

5. Interest Paid:
It represents interest paid on loans, debt or borrowings, in the direct cash flow method.

Firebrick Pharma's cash payments for the six months ended in Dec. 2024 was A$0.00 Mil.

6. Interest Received:
It represents interest received by the company in the direct cash flow method.

Firebrick Pharma's cash payments for the six months ended in Dec. 2024 was A$0.01 Mil.

7. Taxes Refund Paid:
It represents tax paid or refund related to operating activities in the direct cash flow method.

Firebrick Pharma's cash payments for the six months ended in Dec. 2024 was A$0.00 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of cash receipts and cash payments. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its cash position will grow more slowly (or even shrink).

Firebrick Pharma's cash flow from others for the six months ended in Dec. 2024 was A$0.00 Mil.

Firebrick Pharma Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Firebrick Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Cash Flow from Operations

Comparable Companies

Traded in Other Exchanges

N/A

Address

440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000

Website

https://www.firebrickpharma.com

Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of povidone-iodine (PVP-I) products under the Nasodine brand. Its Nasodine Nasal Spray which is in the commercialization phase, is a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold. In parallel, the company is also engaged in the development of the follow-on Nasodine brand products.

Firebrick Pharma Headlines

No Headlines